United States Cardiac Ablation Devices Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities

Market Size and Growth

Cardiac Ablation Devices Market size was valued USD 4,067.2 million in 2021 and is estimated to reach USD 10,894.3 million by 2031, growing at a CAGR of 12.85% during the forecast period (2024-2031).

Key Development:

United States: Recent Industry Developments

✅ In July 2025, Kardium secured $250 million in funding to advance its pulsed field ablation (PFA) system for atrial fibrillation treatment. The company aims to launch the system in the U.S. market soon.

✅ In April 2025, Merit Medical launched the Ventrax Delivery System in the U.S. This device is designed for ventricular tachycardia ablation, offering improved catheter reach through retrograde aortic access.

✅ In February 2025, Johnson & Johnson paused U.S. sales of its VaripulseTM heart-rhythm device due to safety concerns, including reports of neurovascular events such as strokes. Despite this, the company continues commercialization efforts outside the U.S.

Japan: Recent Industry Developments

✅ In September 2025, CardioFocus expanded its partnership with Japan Lifeline to introduce the HeartLight® Endoscopic Ablation System to the Japanese market. This collaboration aims to enhance atrial fibrillation treatment options in Japan.

✅ In September 2025, Dr. Steven Mickelsen launched Del Medtech, focusing on expanding pulsed field ablation technology beyond cardiac care into areas like gastrointestinal and women's health.

✅ In July 2025, Johnson & Johnson launched its VaripulseTM platform across Asia-Pacific, including Japan. The device integrates with the CARTOTM 3 mapping system to enhance atrial fibrillation treatment.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/cardiac-ablation-devices-market?sb

Cardiac Ablation Devices are medical tools used to treat abnormal heart rhythms (arrhythmias) by delivering energy such as radiofrequency or cryotherapy to targeted heart tissue. This procedure destroys or isolates problematic tissue, restoring normal cardiac rhythm, reducing symptoms, and improving patient quality of life.

United States: Recent Mergers & Acquisitions

✅ In March 2025, Boston Scientific agreed to acquire Cortex, a company specializing in advanced atrial fibrillation (AF) ablation technologies. The acquisition aims to enhance Boston Scientific's electrophysiology portfolio with Cortex's innovative solutions.

✅ In March 2025, Catheter Precision acquired the assets of Cardionomics, Inc., including the Cardiac Pulmonary Nerve Stimulation System. This acquisition introduces a new therapy under development for the treatment of acute decompensated heart failure.

✅ In May 2024, Stereotaxis announced its acquisition of Access Point Technologies (APT), a private company specializing in diagnostic catheters. This deal is expected to bolster Stereotaxis' catheter development and manufacturing capabilities, aiding the advancement of treatments for complex arrhythmias.

Europe: Recent Mergers & Acquisitions

✅ In March 2025, Boston Scientific announced the acquisition of SoniVie Ltd., a private medical device firm in Israel, for approximately USD 360 million upfront, with potential additional payments. This acquisition aims to expand Boston Scientific's interventional cardiology portfolio with ultrasound-based renal denervation therapy for hypertension.

✅ In March 2025, Teleflex entered into an agreement to acquire BIOTRONIK's vascular intervention business. This move reflects Teleflex's commitment to investing in the estimated $10 billion interventional cardiology and peripheral vascular markets. The acquisition is expected to enhance Teleflex's offerings to cardiac and peripheral care specialists.

Key Players:

-> Boston Scientific Corporation, Epix Therapeutics, Acutus Medical, Medtronic, AtriCure, Inc., Biosense Webster, Inc., St Jude Medical, Abbott and Mount Sinai Health System Inc.

Growth Forecast Projected:

The Global Cardiac Ablation Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Cardiac Ablation Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cardiac-ablation-devices-market

Key Segments:

➥ By Product Type: Radiofrequency (RF) Ablation, Electrical Ablation, Cryoablation, Ultrasound Ablation, Microwave Ablation
➥ By Application: Cardiac Rhythm Management, Open Surgery, Others
➥ By End-User: Hospitals, Ambulatory Surgical Centers, Clinics, Others

Regional Analysis for Cardiac Ablation Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Cardiac Ablation Devices producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Cardiac Ablation Devices revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cardiac-ablation-devices-market?sb

FAQ

What is the current size of the Cardiac Ablation Devices Market?

A: In 2021, the Cardiac Ablation Devices Market was valued at USD 4,067.2 million , reflecting its strong industry presence.

Q2: How large is the Cardiac Ablation Devices Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Cardiac Ablation Devices Market will grow to around USD 10,894.3 million, demonstrating significant expansion.

Q3: What is the growth rate of the Cardiac Ablation Devices Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 12.85% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.